Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT07217717Phase 3Recruiting
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Pancreatic Ductal Adenocarcinoma (PDAC)
StudydirectorStart date: 2025-12-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Sofie Co.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Chiara Bonini, MD

Vita-Salute San Raffaele University, IRCCS San Raffaele

Moderately Similar
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Duowu Zou

Ruijin Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Aaron Enke

3B Pharmaceuticals GmbH

Moderately Similar
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Jefferson N Brownell, MD

Children's Hospital of Philadelphia

Moderately Similar
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Bojan Kovacevic, MD, PhD

Herlev Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Lakhmir Chawla, MD

ExThera Medical

Moderately Similar
2 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Ebrahim Delpassand, MD, FACNM

Radiomedix, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Nirav Thosani, MD

The University of Texas Health Science Center, Houston

Moderately Similar
2 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

George Hanna, MBBS; PhD; FRSC

Imperial College London

Moderately Similar
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Giampaolo Perri, MD PhD

University of Padova

Moderately Similar
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma (PDAC)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07217717Phase 3StudyDirector

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting

All 1 trials loaded